Arsenal Capital Partners has completed a strategic investment in OncoHealth, according to a news release.
OncoHealth, based in Atlanta, is a digital health company that combines data and analytics with oncology experts to provide solutions used by health plans, employers, providers, patients and life sciences researchers to help navigate the physical, mental and financial complexities of cancer.
Arsenal, based in New York, is a private equity firm specializing in investments in middle market healthcare and specialty industrials companies. Founded in 2000, the firm seeks control investments in companies with the capacity to use $50 million to $300 million of equity, including add-on acquisitions.
It was also announced that McKesson Corp. invested in OncoHealth.
Terms of the investments were not disclosed.